Post Translational Medicines
Latest round
- Seed
Last raised
- Jul 2025
Total raised
- Undisclosed
Investors
- 1
About Post Translational Medicines
Founded in 2025, Post Translational Medicines Inc specializes in drug discovery, particularly through their Surveyor™ Platform, which decodes proteoforms for novel treatments. The company has completed 1 deal as of July 31, 2025.Post Translational Medicines specializes in drug discovery through the innovative exploration and targeting of the Dark Proteome, which consists of previously undruggable therapeutic targets. Their flagship offering, the Surveyor™ Platform, systematically decodes the complex landscape of proteoforms, enabling novel in cellulo drug discovery. This technology serves pharmaceutical companies and research institutions seeking new therapeutic pathways for historically difficult-to-treat diseases. The company's solutions are applicable in North America, Europe, and select regions in Asia, where biopharmaceutical research is prioritized.Post Translational Medicines generates revenue through partnerships and collaborations with leading pharmaceutical and biotechnology firms, focusing on B2B transactions. These engagements typically involve licensing their Surveyor™ Platform technology and research agreements targeting specific proteoforms. The company is also targeting expansion into additional markets, with specific plans for North America and Europe by 2026 to increase their global footprint and leverage the growing demand for biopharmaceutical research.
Who invested in Post Translational Medicines
1 investor across 1 round
See all investors in Post Translational Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 31, 2025
Amount
Undisclosed
Investors
Questions about Post Translational Medicines
Who invested in Post Translational Medicines?
Post Translational Medicines has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Post Translational Medicines raised?
Post Translational Medicines has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Post Translational Medicines last raise money?
Post Translational Medicines's most recent round on record is a Seed, in Jul 2025.
What does Post Translational Medicines do?
Founded in 2025, Post Translational Medicines Inc specializes in drug discovery, particularly through their Surveyor™ Platform, which decodes proteoforms for novel treatments.
Where is Post Translational Medicines headquartered?
Post Translational Medicines is headquartered in Singapore.
Which VCs invest in companies like Post Translational Medicines?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back healthcare specialists companies at Post Translational Medicines's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Seed
Raising like Post Translational Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.